Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Adenovirus · Cytomegalovirus Infections · Epstein-Barr Virus Infections
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Jessie Alexander, Palo Alto, California, United States
Lucile Packard Children's Hospital, Palo Alto, California, United States
Lucile Packard Children's Hospital, Palo Alto, California, United States
Contact: Study coordinator (SCGT Clinical Trials Program) · DL-SCTIntakeCoordinators@stanfordchildrens.org · 650-723-0912
Study leads
Jessie Alexander, MD
Principal Investigator
Stanford University